Table 2 Immune-related signatures used in the study including HLA-A and -B, IFN gamma signature, expanded immune gene signature, and cytotoxic T lymphocyte (CTL) signature, and their corresponding genes
From: A promising Prognostic risk model for advanced renal cell carcinoma (RCC) with immune-related genes
Signature | Gene |
|---|---|
HLA class I molecules | HLA-A, HLA-B |
IFN gamma signature | IDO1, CXCL10, CXCL9, HLA-DRA, IFNG |
Expanded immune gene signature | CD30(TNFRSF8), IDO1, CIITA, CD3E, CCL5, GZMK, CD2, HLA-DRA, CXCL13, NKG7, HLA-E, CXCR6, LAG3, TAGAP, CXCL10, STAT1, GZMB |
Cytotoxic T lymphocyte (CTL) level signature | CD8A, CD8B, GZMA, GZMB, PRF1 |